Corey L. Stanchina

Fit-for-Purpose Development of the Enabling Route to Crizotinib (PF-02341066)

Pieter D. de Koning, Douglas McAndrew, Robert Moore et al. · Organic Process Research & Development · 2011 · 89 citations

Medicinal Chemistry, Boronate 8, Bioorganic Chemistry +14

Commercial Route Research and Development for SGLT2 Inhibitor Candidate Ertugliflozin

Paul Bowles, Steven J. Brenek, Stéphane Caron et al. · Organic Process Research & Development · 2013 · 66 citations

Combinatorial Chemistry, Bioorganic Chemistry, Organic Chemistry +19

Regio- and stereoselective synthesis of N-H aziridines N-N bond reduction ofN-quinazolinylaziridines

Ali Koohang, Corey L. Stanchina, Robert M. Coates · Tetrahedron · 1999 · 31 citations

Engineering, Heterocyclic, Organic Chemistry +5

Continuous Reaction/Crystallization Process for Production of a Hazardous Intermediate

John G. Van Alsten, Lisa M. Reeder, Corey L. Stanchina et al. · Organic Process Research & Development · 2008 · 26 citations

Engineering, Organic Chemistry, Chemistry +19

Synthesis of Filibuvir. Part I. Diastereoselective Preparation of a β-Hydroxy Alkynyl Oxazolidinone and Conversion to a 6,6-Disubstituted 2<i>H</i>-Pyranone

Robert A. Singer, John A. Ragan, Paul Bowles et al. · Organic Process Research & Development · 2013 · 24 citations

Dieckmann Cyclization, β-Hydroxy Alkynyl Oxazolidinone, Biosynthesis +14